Table 2.
Number of therapeutic trials in each working group by year, 2005–2010 at Siteman Cancer Center
| 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | Chi-square | df | p | |
|---|---|---|---|---|---|---|---|---|---|
| Leukemia/lymphoma/transplant | 20 | 21 | 24 | 26 | 24 | 31 | 3.18 | 5 | 0.6726 |
| Breast oncology | 16 | 19 | 19 | 20 | 17 | 16 | 0.83 | 5 | 0.9750 |
| Gynecologic oncology | 8 | 8 | 7 | 9 | 10 | 11 | 1.23 | 5 | 0.9423 |
| Gastrointestinal - lower | 9 | 11 | 10 | 10 | 8 | 4 | 3.62 | 5 | 0.6060 |
| Gastrointestinal - upper | 9 | 8 | 6 | 4 | 7 | 11 | 3.93 | 5 | 0.5591 |
| Thoracic oncology | 3 | 5 | 9 | 9 | 9 | 8 | 4.58 | 5 | 0.4691 |
| Genitourinary oncology | 9 | 6 | 7 | 7 | 5 | 4 | 2.42 | 5 | 0.7883 |
| Developmental therapeutics | 5 | 4 | 2 | 5 | 7 | 7 | 3.60 | 5 | 0.6083 |
| Head & neck oncology | 3 | 2 | 5 | 7 | 4 | 4 | 3.56 | 5 | 0.6143 |
| Pediatric oncology | 5 | 3 | 3 | 3 | 3 | 0 | 4.53 | 5 | 0.4760 |
| Neuro-oncology | 0 | 0 | 1 | 3 | 5 | 3 | 10.00 | 5 | 0.0752 |
| N/A | 1 | 1 | 1 | 1 | 1 | 3 | 2.50 | 5 | 0.7765 |
| Musculoskeletal oncology | 0 | 0 | 0 | 1 | 3 | 3 | 9.29 | 5 | 0.0982 |
| Endocrine oncology | 2 | 1 | 1 | 1 | 1 | 0 | 2.00 | 5 | 0.8491 |
| Melanoma | 0 | 0 | 0 | 2 | 2 | 2 | 6.00 | 5 | 0.3062 |
†
working groups not listed here had no therapeutic trials